Bioequivalence Expert Pharmaceutical Consultants

Lachman Consultants, the leader in providing cost-effective consultation and remediation services to the worldwide pharmaceutical, biotechnology, biologic, medical device, diagnostic and dietary supplement industries, is seeking accomplished Bioequivalence experts for pharmaceutical, biotechnology, and medical device products. The Bioequivalence professional must have a strong background and demonstrable hands-on experience and skills. Qualifications / Responsibilities include: Bioavailability / bioequivalence expertise Bioequivalence strategies for diverse dosage forms Biopharmaceutics and Regulatory science GCP and GLP audits Formulation development; dissolution methods/reviews; interpretation of dissolution data Study design and protocol development Bioequivalence studies Pharmacokinetic, pharmacodynamic, and clinical endpoint studies Bioanalytical method validation Statistical data analyses US and global regulatory requirements US FDA / global applications / submissions Due diligence reviews of bioequivalence reports Ability to lead projects and meet crucial timelines Superb written and oral communication skills Excellent interpersonal and soft skills Ability to solve problems using innovative techniques Educational / Experience Requirements include: B.S. life sciences and 10 years’ relevant experience. Apply to:

http://www.lachmanconsultants.com/career-opportunities/ For four decades, Lachman Consultants has been the leader in providing cost-effective consultation and remediation services to the worldwide pharmaceutical, biotechnology, biologic, medical device, diagnostic and dietary supplement industries. With its strong and extensive cadre of consultant specialists and an unparalleled management team, its Compliance, Science & Technology, and Regulatory Practices provide the most expert counsel and array of services available. Lachman Consultants is proud of its tradition of supporting industry efforts to develop and ensure safe, effective, and high-quality medical products. It remains committed to helping the industry anticipate and address its challenges through the development and implementation of practical, sustainable, and cost-effective solutions based on the integration of scientific principles, evolving regulatory expectations, and technology.

#J-18808-Ljbffr